Skip to main content
logo
Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.945
-0.020 (-0.67%)
Aug 13, 2026, 5:29 PM CET

Elicera Therapeutics AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
19825359907099
Market Cap Growth
-33.49%332.31%-35.03%29.73%-29.98%-
Enterprise Value
180.01228.5132.2160.8225.7146.91
Last Close Price
2.955.221.674.563.525.02

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.6023.348.228.0354.32169175.00
PB Ratio
10.8110.852.825.502.121.90
P/TBV Ratio
7.8110.242.545.502.501.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
16.9221.054.525.4220.0879919.10

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.98-1.06-1.27-1.79-1.34-1.00
Net Debt / EBITDA Ratio
1.191.391.571.722.274.00
Net Debt / FCF Ratio
1.011.151.131.975.114.00
Asset Turnover
0.440.390.250.290.030.00
Quick Ratio
7.126.134.012.163.2721.04
Current Ratio
8.046.754.062.193.3921.68
Return on Equity (ROE)
-69.38%-78.88%-86.68%-66.66%-45.72%-42.00%
Return on Assets (ROA)
-62.04%-65.27%-58.48%-44.70%-38.32%-38.97%
Return on Capital Employed (ROCE)
-71.96%-81.32%-90.83%-69.49%-45.54%-42.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-36.74%-45.01%-59.89%15.31%-30.38%-419.70%
Total Shareholder Return
-36.74%-45.01%-59.89%15.31%-30.38%-419.70%